For: | Detlie TE, Lindstrøm JC, Jahnsen ME, Finnes E, Zoller H, Moum B, Jahnsen J. Hypophosphatemia after high-dose intravenous iron treatment in patients with inflammatory bowel disease: Mechanisms and possible clinical impact. World J Gastroenterol 2021; 27(17): 2039-2053 [PMID: 34007138 DOI: 10.3748/wjg.v27.i17.2039] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v27/i17/2039.htm |
Number | Citing Articles |
1 |
Alexander Kaserer, Julia Braun, Alexander Mair, Samira Akbas, Julian Rössler, Heike A. Bischoff-Ferrari, Matthias Turina, Pierre-Alain Clavien, Isabelle Opitz, Andreas Hülsmeier, Gergely Karsai, Greta Gasciauskaite, Gabriela H. Spahn, Martin Schläpfer, Donat R. Spahn. Ferric carboxymaltose with or without phosphate substitution in iron deficiency or iron deficiency anemia before elective surgery – The DeFICIT trial. Journal of Clinical Anesthesia 2025; 101: 111727 doi: 10.1016/j.jclinane.2024.111727
|
2 |
Edyta Tulewicz-Marti, Paulina Szwarc, Martyna Więcek, Konrad Lewandowski, Tomasz Korcz, Malgorzata Cicha, G. Rydzewska. Effect of Intravenous Iron Administration on Bone Mineral and Iron Homeostasis in Patients with Inflammatory Bowel Disease—Results of a Prospective Single-Centre Study. Journal of Personalized Medicine 2023; 13(3): 458 doi: 10.3390/jpm13030458
|